DMAC   $4.18  3.98% Market Closed

DiaMedica Therapeutics Inc
Total Cash 54.05M
totalCashPerShare 1.265
EBITDA -22.35M
Total Debt 388.00K
quickRatio 17.631
currentRatio 17.815
Total Revenue
debtToEquity 0.726
Revenue/Share
ROA -0.23544
ROE -0.35176
grossProfits
freeCashflow -11.14M
operatingCashflow -19.78M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 133.14M
forwardPE -5.885135
floatShares 26.26M
sharesOutstanding 42.75M
sharesShort 183.29K
sharesShortPriorMonth 138.44K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.26%
heldPercentInstitutions 0.31%
Short Ratio help_outline 3.00%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 1.251
Price To Book help_outline 3.48
earningsQuarterlyGrowth
netIncomeToCommon -19.90M
trailingEps -0.51%
forwardEps -0.74%
enterpriseToEbitda -5.96
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.15 3Q 2024
institutionsCount 48
lastUpdated Nov. 6, 2024, 10:28 p.m.